HomeCompareTT vs HRC

TT vs HRC: Dividend Comparison 2026

TT yields 0.96% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $1.96M in total portfolio value
10 years
TT
TT
● Live price
0.96%
Share price
$403.93
Annual div
$3.87
5Y div CAGR
77.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$297.1K
Annual income
$177,604.16
Full TT calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — TT vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTTHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TT + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TT pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TT
Annual income on $10K today (after 15% tax)
$81.44/yr
After 10yr DRIP, annual income (after tax)
$150,963.54/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,058,951.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TT + HRC for your $10,000?

TT: 50%HRC: 50%
100% HRC50/50100% TT
Portfolio after 10yr
$1.28M
Annual income
$800,516.90/yr
Blended yield
62.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TT right now

TT
Analyst Ratings
10
Buy
14
Hold
1
Sell
Consensus: Hold
Price Target
$471.88
+16.8% upside vs current
Range: $370.00 — $520.00
Altman Z
6.6
Piotroski
8/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TT buys
7
HRC buys
0
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-12-23
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-12-05
Valerie Hoyle🏢 House$TT▲ Buy$1,001 - $15,0002024-10-29
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-09-27
John James🏢 House$TT▼ Sell$1,001 - $15,0002024-09-04
Josh Gottheimer🏢 House$TT▼ Sell$1,001 - $15,0002024-07-01
Ro Khanna🏢 House$TT▲ Buy$50,001 - $100,0002024-06-20
John James🏢 House$TT▲ Buy$1,001 - $15,0002023-11-10
Ro Khanna🏢 House$TT▼ Sell$15,001 - $50,0002023-10-31
Ro Khanna🏢 House$TT▲ Buy$15,001 - $50,0002023-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTTHRC
Forward yield0.96%11.38%
Annual dividend / share$3.87$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR77.2%40.3%
Portfolio after 10y$297.1K$2.26M
Annual income after 10y$177,604.16$1,423,429.65
Total dividends collected$265.9K$2.14M
Payment frequencyquarterlyquarterly
SectorIndustrialsStock
Analyst consensusHoldHold

Year-by-year: TT vs HRC ($10,000, DRIP)

YearTT PortfolioTT Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$10,870$169.77$12,296$1,595.93$1.4KHRC
2$11,936$305.61$15,730$2,573.05$3.8KHRC
3$13,328$555.77$21,147$4,316.00$7.8KHRC
4$15,288$1,027.68$30,235$7,608.15$14.9KHRC
5$18,311$1,952.29$46,615$14,263.36$28.3KHRC
6$23,465$3,872.33$78,712$28,834.27$55.2KHRC
7$33,325$8,217.96$148,063$63,841.01$114.7KHRC
8$54,987$19,328.64$315,890$157,462.80$260.9KHRC
9$111,652$52,815.95$778,498$440,495.17$666.8KHRC
10$297,071$177,604.16$2,256,422$1,423,429.65$1.96MHRC

TT vs HRC: Complete Analysis 2026

TTIndustrials

Trane Technologies plc, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of solutions for heating, ventilation, air conditioning, and transport refrigeration. It offers air conditioners, exchangers, and handlers; airside and terminal devices; auxiliary power units; chillers; coils and condensers; gensets; furnaces; heat pumps; home automation products; humidifiers; hybrid and non-diesel transport refrigeration, and ice energy storage solutions; indoor air quality assessments and related products; large and light commercial unitary products; motor replacements; refrigerant reclamation products; thermostats/controls; transport heater products; variable refrigerant flow products; and water source heat pumps. The company also provides building management, control, ductless, geothermal, package heating and cooling, temporary heating and cooling, and unitary systems; bus, rail, and multi-pipe heating, ventilation, and air conditioning systems; and container, cryogenic, diesel-powered, electric-powered trailer and truck, hybrid-powered trailer, industrial, rail, self-powered truck, trailer, and vehicle-powered truck refrigeration systems, as well as aftermarket and OEM parts and supplies. In addition, it offers energy and facility management, installation and performance contracting, repair and maintenance, and rental services. It markets and sells its products under the Trane and Thermo King brands through sales offices, distributors, and dealers in the United States; and through sales and service companies with a supporting chain of distributors worldwide. The company was formerly known as Ingersoll-Rand Plc and changed its name to Trane Technologies plc in March 2020. Trane Technologies plc was founded in 1885 and is headquartered in Swords, Ireland.

Full TT Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this TT vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TT vs SCHDTT vs JEPITT vs OTT vs KOTT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.